Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Leeson

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry|July 29, 1998
3-(1-piperazinyl)-4,5-dihydro-1H-benzo[g]indazoles: high affinity ligands for the human dopamine D4 receptor with improved selectivity over ion channelsI Collins, M Rowley, W B Davey, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedativeL Singh, A E Donald, A C Foster, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptorS Bourrain, I Collins, J G Neduvelil, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complexL J Bristow, P H Hutson, J J Kulagowski, et al.
Journal of Medicinal Chemistry|April 1, 1991
Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptorP D Leeson, R Baker, R W Carling, et al.
Journal of Medicinal Chemistry|July 18, 1997
4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptorM Rowley, I Collins, H B Broughton, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral testsL J Bristow, N Collinson, G P Cook, et al.
Journal of Medicinal Chemistry|May 10, 1996
3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptorJ J Kulagowski, H B Broughton, N R Curtis, et al.
Journal of Medicinal Chemistry|July 20, 1999
1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1, 3-dihydroimidazol-2-one: a selective high-affinity antagonist for the human dopamine D(4) receptor with excellent selectivity over ion channelsR W Carling, K W Moore, C R Moyes, et al.
Journal of Medicinal Chemistry|February 28, 1997
4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activityR W Carling, P D Leeson, K W Moore, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|July 29, 1998
3-(1-piperazinyl)-4,5-dihydro-1H-benzo[g]indazoles: high affinity ligands for the human dopamine D4 receptor with improved selectivity over ion channelsI Collins, M Rowley, W B Davey, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedativeL Singh, A E Donald, A C Foster, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptorS Bourrain, I Collins, J G Neduvelil, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complexL J Bristow, P H Hutson, J J Kulagowski, et al.
Journal of Medicinal Chemistry|April 1, 1991
Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptorP D Leeson, R Baker, R W Carling, et al.
Journal of Medicinal Chemistry|July 18, 1997
4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptorM Rowley, I Collins, H B Broughton, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral testsL J Bristow, N Collinson, G P Cook, et al.
Journal of Medicinal Chemistry|May 10, 1996
3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptorJ J Kulagowski, H B Broughton, N R Curtis, et al.
Journal of Medicinal Chemistry|July 20, 1999
1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1, 3-dihydroimidazol-2-one: a selective high-affinity antagonist for the human dopamine D(4) receptor with excellent selectivity over ion channelsR W Carling, K W Moore, C R Moyes, et al.
Journal of Medicinal Chemistry|February 28, 1997
4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activityR W Carling, P D Leeson, K W Moore, et al.
Pageof 5